Shefali Chaudhary1, S Senthil Kumaran2, Vinay Goyal3, M Kalaivani4, Gauri Shanker Kaloiya5, Rajesh Sagar6, Nalin Mehta7, Achal Kumar Srivastava3, N R Jagannathan1. 1. Department of NMR & MRI Facility, All India Institute of Medical Sciences, New Delhi, 110029, India. 2. Department of NMR & MRI Facility, All India Institute of Medical Sciences, New Delhi, 110029, India. senthil@aiims.edu. 3. Department of Neurology, All India Institute of Medical Sciences, New Delhi, 110029, India. 4. Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, 110029, India. 5. National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, 110029, India. 6. Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, 110029, India. 7. Department of Physiology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Abstract
BACKGROUND AND PURPOSE: Diagnosis of Parkinson's disease (PD) cognitive impairment at early stages is challenging compared to the stage of PD dementia where functional impairment is apparent and easily diagnosed. Hence, to evaluate potential early stage cognitive biomarkers, we assessed frontal lobe metabolic alterations using in vivo multi-voxel proton magnetic resonance spectroscopic imaging (1H-MRSI). METHOD: Frontal metabolism was studied in patients with PD with normal cognition (PD-CN) (n = 26), with cognitive impairment (PD-CI) (n = 27), and healthy controls (HC) (n = 30) using a single slice (two-dimensional) 1H-MRSI at 3 T. The acquired spectra were post-processed distinctly for voxels corresponding to the bilateral middle/superior frontal gray matter (GM) and frontal white matter (WM) regions (delineated employing neuromorphometrics atlas) using the LC-Model software. RESULT: Significant (post hoc p < 0.016) reduction in the concentration of N-acetyl aspartate (NAA) in the middle and superior frontal GMs and total choline (tCho) and total creatine (tCr) in the frontal WM was observed in PD-CI compared to PD-CN and HC, while that in HC and PD-CN groups were comparable. The NAA and tCr/tCho metabolite concentrations showed significant (p < 0.05) positive correlations with cognitive test scores in the frontal GM and WM, respectively. The receiver operating curve (ROC) analysis revealed significant (p < 0.05) "area under curve" for NAA/tNAA in the frontal GM and tCho in the frontal WM. CONCLUSION: The frontal metabolic profile is altered in cognitively impaired PD compared with cognitively normal PD. Neuronal function loss (NAA), altered energy metabolism (Cr), and cholinergic (Cho) neural transmission are implicated in PD cognitive pathology. Frontal neuro-metabolism may promisingly serve as PD cognitive biomarker.
BACKGROUND AND PURPOSE: Diagnosis of Parkinson's disease (PD) cognitive impairment at early stages is challenging compared to the stage of PD dementia where functional impairment is apparent and easily diagnosed. Hence, to evaluate potential early stage cognitive biomarkers, we assessed frontal lobe metabolic alterations using in vivo multi-voxel proton magnetic resonance spectroscopic imaging (1H-MRSI). METHOD: Frontal metabolism was studied in patients with PD with normal cognition (PD-CN) (n = 26), with cognitive impairment (PD-CI) (n = 27), and healthy controls (HC) (n = 30) using a single slice (two-dimensional) 1H-MRSI at 3 T. The acquired spectra were post-processed distinctly for voxels corresponding to the bilateral middle/superior frontal gray matter (GM) and frontal white matter (WM) regions (delineated employing neuromorphometrics atlas) using the LC-Model software. RESULT: Significant (post hoc p < 0.016) reduction in the concentration of N-acetyl aspartate (NAA) in the middle and superior frontal GMs and total choline (tCho) and total creatine (tCr) in the frontal WM was observed in PD-CI compared to PD-CN and HC, while that in HC and PD-CN groups were comparable. The NAA and tCr/tCho metabolite concentrations showed significant (p < 0.05) positive correlations with cognitive test scores in the frontal GM and WM, respectively. The receiver operating curve (ROC) analysis revealed significant (p < 0.05) "area under curve" for NAA/tNAA in the frontal GM and tCho in the frontal WM. CONCLUSION: The frontal metabolic profile is altered in cognitively impaired PD compared with cognitively normal PD. Neuronal function loss (NAA), altered energy metabolism (Cr), and cholinergic (Cho) neural transmission are implicated in PD cognitive pathology. Frontal neuro-metabolism may promisingly serve as PD cognitive biomarker.
Authors: Mustafa Almuqbel; Tracy R Melzer; Daniel J Myall; Michael R MacAskill; Toni L Pitcher; Leslie Livingston; Kyla-Louise Wood; Ross J Keenan; John C Dalrymple-Alford; Tim J Anderson Journal: Parkinsonism Relat Disord Date: 2015-11-12 Impact factor: 4.891
Authors: C Lucetti; P Del Dotto; G Gambaccini; S Bernardini; M C Bianchi; M Tosetti; U Bonuccelli Journal: Neurol Sci Date: 2001-02 Impact factor: 3.307
Authors: D Aarsland; J T Kvaløy; K Andersen; J P Larsen; M X Tang; A Lolk; P Kragh-Sørensen; K Marder Journal: J Neurol Date: 2007-02-14 Impact factor: 4.849
Authors: Jennifer G Goldman; Beth A Vernaleo; Richard Camicioli; Nabila Dahodwala; Roseanne D Dobkin; Terry Ellis; James E Galvin; Connie Marras; Jerri Edwards; Julie Fields; Robyn Golden; Jason Karlawish; Bonnie Levin; Lisa Shulman; Glenn Smith; Christine Tangney; Cathi A Thomas; Alexander I Tröster; Ergun Y Uc; Noreen Coyan; Crystal Ellman; Mike Ellman; Charlie Hoffman; Susan Hoffman; Don Simmonds Journal: NPJ Parkinsons Dis Date: 2018-06-26
Authors: Vera Filippi; Ruth Steiger; Vincent Beliveau; Florian Frank; Katharina Kaltseis; Elke R Gizewski; Gregor Broessner Journal: Brain Sci Date: 2022-05-14